SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 77 filers reported holding SAVARA INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $75,347 | -7.0% | 19,933 | -21.4% | 0.00% | – |
| Q2 2023 | $81,032 | -50.0% | 25,362 | -67.5% | 0.00% | – |
| Q1 2021 | $162,000 | +102.5% | 78,080 | +11.6% | 0.00% | – |
| Q4 2020 | $80,000 | +5.3% | 69,994 | 0.0% | 0.00% | – |
| Q3 2020 | $76,000 | -56.3% | 69,994 | 0.0% | 0.00% | – |
| Q2 2020 | $174,000 | +54.0% | 69,994 | +31.3% | 0.00% | – |
| Q1 2020 | $113,000 | -52.1% | 53,298 | +1.2% | 0.00% | – |
| Q4 2019 | $236,000 | +65.0% | 52,680 | -2.6% | 0.00% | – |
| Q3 2019 | $143,000 | +23.3% | 54,061 | +10.5% | 0.00% | – |
| Q2 2019 | $116,000 | -64.1% | 48,908 | +11.5% | 0.00% | -100.0% |
| Q1 2019 | $323,000 | -6.6% | 43,876 | -4.1% | 0.00% | 0.0% |
| Q4 2018 | $346,000 | -29.0% | 45,744 | +4.9% | 0.00% | 0.0% |
| Q3 2018 | $487,000 | +12.5% | 43,599 | +14.0% | 0.00% | 0.0% |
| Q2 2018 | $433,000 | – | 38,248 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 3,313,602 | $12,525,416 | 47.59% |
| NEA Management Company, LLC | 24,471,264 | $92,501,378 | 7.14% |
| Bain Capital Life Sciences Investors, LLC | 14,232,751 | $53,799,799 | 6.02% |
| TCG Crossover Management, LLC | 10,000,000 | $37,800,000 | 5.57% |
| VR Adviser, LLC | 7,184,865 | $27,158,790 | 2.86% |
| Affinity Asset Advisors, LLC | 1,150,000 | $4,347,000 | 1.22% |
| Sio Capital Management, LLC | 896,250 | $3,387,825 | 1.05% |
| Frazier Life Sciences Management, L.P. | 4,000,000 | $15,120,000 | 1.00% |
| Vivo Capital, LLC | 1,913,349 | $7,232,459 | 0.79% |
| Nantahala Capital Management | 1,039,364 | $3,928,796 | 0.34% |